Morgan Stanley
PRAX icon

Morgan Stanley’s Praxis Precision Medicines PRAX Stock Holding History

Morgan Stanley’s Portfolio PRAX Stock Details PRAX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$286M Buy
854,112
+20,621
+2% +$6.53M 0.02% 821
2026
Q1 		$269M Sell
833,491
-56,398
-6% -$17.4M 0.02% 801
2025
Q4 		$262M Buy
889,889
+246,394
+38% +$45.9M 0.02% 800
2025
Q3 		$34.1M Sell
643,495
-582,844
-48% -$28.3M ﹤0.01% 2361
2025
Q2 		$51.6M Buy
1,226,339
+12,670
+1% +$483K ﹤0.01% 1904
2025
Q1 		$46M Buy
1,213,669
+50,143
+4% +$3.13M ﹤0.01% 1884
2024
Q4 		$89.5M Buy
1,163,526
+1,083,026
+1,345% +$78.4M 0.01% 1340
2024
Q3 		$4.63M Sell
80,500
-103,819
-56% -$5.61M ﹤0.01% 4018
2024
Q2 		$7.62M Buy
184,319
+84,183
+84% +$3.98M ﹤0.01% 3539
2024
Q1 		$6.11M Buy
100,136
+83,203
+491% +$3.73M ﹤0.01% 3760
2023
Q4 		$377K Sell
16,933
-2,415
-12% -$43.5K ﹤0.01% 5436
2023
Q3 		$496K Buy
19,348
+3,148
+19% +$59.6K ﹤0.01% 5177
2023
Q2 		$279K Sell
16,200
-39,036
-71% -$598K ﹤0.01% 5494
2023
Q1 		$670K Buy
55,236
+43,099
+355% +$1.82M ﹤0.01% 5086
2022
Q4 		$433K Sell
12,137
-6,188
-34% -$193K ﹤0.01% 5314
2022
Q3 		$624K Sell
18,325
-16,823
-48% -$838K ﹤0.01% 5152
2022
Q2 		$1.29M Buy
35,148
+30,341
+631% +$3.24M ﹤0.01% 4852
2022
Q1 		$737K Buy
4,807
+3,454
+255% +$710K ﹤0.01% 5172
2021
Q4 		$400K Buy
1,353
+387
+40% +$114K ﹤0.01% 5681
2021
Q3 		$267K Sell
966
-5,702
-86% -$1.55M ﹤0.01% 5849
2021
Q2 		$1.83M Buy
6,668
+6,374
+2,168% +$2.28M ﹤0.01% 4698
2021
Q1 		$144K Sell
294
-661
-69% -$470K ﹤0.01% 5832
2020
Q4 		$788K Buy
+955
New +$557K ﹤0.01% 4794

Other funds holding PRAX

JT
Jupiter Topco New York $245B AUM
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
PA
Perceptive Advisors New York $6.66B AUM 360.84% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $20B AUM 154.41% 1-Year Est. Return
OAG
Orbis Allan Gray Hamilton, Bermuda $29.1B AUM 60.8% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $71.3B AUM 56.8% 1-Year Est. Return

Morgan Stanley's PRAX Position: Q2 2026 in Review

Morgan Stanley increased its Praxis Precision Medicines (PRAX) stake by 2.5% in Q2 2026, buying an estimated $6.53M and bringing the position to 854,112 shares worth $286M. The position accounts for 0.02% of the portfolio, ranked #821.

Morgan Stanley first reported a position in PRAX in Q4 2020 and has held it in 23 quarters since. 309 funds tracked by Wall St. Rank hold PRAX as of Q2 2026.

  • Morgan Stanley held 854,112 shares of Praxis Precision Medicines worth $286M as of Q2 2026.
  • Morgan Stanley bought 20,621 Praxis Precision Medicines shares in Q2 2026, an estimated $6.53M.
  • Praxis Precision Medicines made up 0.02% of Morgan Stanley's portfolio in Q2 2026, its #821 holding.
  • Morgan Stanley first reported a position in Praxis Precision Medicines in Q4 2020 and has held it in 23 quarters since.
  • 309 funds tracked by Wall St. Rank held Praxis Precision Medicines as of Q2 2026.

Based on Morgan Stanley's 13F filing for Q2 2026, filed 13 Aug 2026.